Newcastle Private Hospital

New Lambton Heights, New South Wales 2305

1 studies enrolling now · 10 studies all time

What they study most

Adenoid Cystic Carcinoma, Advanced Solid Tumor, Cancer Harboring BRAF Alterations, Cervical Cancer, Complete Response, Endometrial Cancer, Epithelial Ovarian Cancer, Esophageal Cancer, FIGO Stage III-IV, Fallopian Tube Cancer, Gastric Cancer, Gastro-Oesophageal Cancer

Studies at this site

• A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations — Recruiting now
• Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer — Running, not enrolling
• RegoNivo vs Standard of Care Chemotherapy in AGOC — Completed
• Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma — Running, not enrolling
• A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression — Completed
• A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy — Running, not enrolling
• Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC — Running, not enrolling
• Nivolumab and Temozolomide Versus Temozolomide Alone in Newly Diagnosed Elderly Patients With GBM — Running, not enrolling
• A Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer — Status unconfirmed
• A Study Comparing CO-1.01 With Gemcitabine as First Line Therapy in Patients With Metastatic Pancreatic Adenocarcinoma (LEAP) — Completed